NO981136D0 - Farmasöytiske kombinasjonspreparater inneholdende erytropoietin og jernpreparater - Google Patents

Farmasöytiske kombinasjonspreparater inneholdende erytropoietin og jernpreparater

Info

Publication number
NO981136D0
NO981136D0 NO981136A NO981136A NO981136D0 NO 981136 D0 NO981136 D0 NO 981136D0 NO 981136 A NO981136 A NO 981136A NO 981136 A NO981136 A NO 981136A NO 981136 D0 NO981136 D0 NO 981136D0
Authority
NO
Norway
Prior art keywords
preparations
combined pharmaceutical
iron
containing erythropoietin
pharmaceutical preparations
Prior art date
Application number
NO981136A
Other languages
English (en)
Other versions
NO981136L (no
NO329908B1 (no
Inventor
Paul Lehmann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO981136L publication Critical patent/NO981136L/no
Publication of NO981136D0 publication Critical patent/NO981136D0/no
Publication of NO329908B1 publication Critical patent/NO329908B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO19981136A 1995-09-14 1998-03-13 Anvendelse av erytropoietin og et jernpreparat for fremstilling av et farmasoytisk kombinasjonspreparat for behandling av hemodialysepasienter, eller for behandling av anemier NO329908B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19535571A DE19535571A1 (de) 1995-09-14 1995-09-14 Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
PCT/EP1996/003997 WO1997009996A1 (de) 1995-09-14 1996-09-12 Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate

Publications (3)

Publication Number Publication Date
NO981136L NO981136L (no) 1998-03-13
NO981136D0 true NO981136D0 (no) 1998-03-13
NO329908B1 NO329908B1 (no) 2011-01-24

Family

ID=7773098

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19981136A NO329908B1 (no) 1995-09-14 1998-03-13 Anvendelse av erytropoietin og et jernpreparat for fremstilling av et farmasoytisk kombinasjonspreparat for behandling av hemodialysepasienter, eller for behandling av anemier

Country Status (26)

Country Link
US (2) US6333306B1 (no)
EP (1) EP0851762B1 (no)
JP (1) JP4783482B2 (no)
KR (1) KR100350761B1 (no)
CN (1) CN1133463C (no)
AT (1) ATE216256T1 (no)
AU (1) AU724623B2 (no)
BR (1) BR9609971A (no)
CA (1) CA2231192C (no)
CZ (1) CZ291427B6 (no)
DE (3) DE19535571A1 (no)
DK (1) DK0851762T3 (no)
EE (1) EE03856B1 (no)
ES (1) ES2174107T3 (no)
HU (1) HU225363B1 (no)
IL (2) IL123640A0 (no)
MX (1) MX9801922A (no)
NO (1) NO329908B1 (no)
NZ (1) NZ319132A (no)
PL (1) PL186776B1 (no)
PT (1) PT851762E (no)
SK (1) SK285796B6 (no)
TR (1) TR199800472T1 (no)
UA (1) UA57713C2 (no)
WO (1) WO1997009996A1 (no)
ZA (1) ZA967732B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0977582T1 (en) * 1997-03-18 2002-12-31 Roche Diagnostics Gmbh Pharmaceutical combined preparations containing erythropoietin and iron preparations
EP0885613A1 (de) * 1997-06-21 1998-12-23 Roche Diagnostics GmbH Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
US7304150B1 (en) 1998-10-23 2007-12-04 Amgen Inc. Methods and compositions for the prevention and treatment of anemia
AR020848A1 (es) * 1998-10-23 2002-05-29 Amgen Inc Metodos y composiciones para la prevencion y el tratamiento de anemia
JP4656814B2 (ja) 2000-12-20 2011-03-23 エフ．ホフマン−ラ ロシュ アーゲー エリスロポエチンコンジュゲート
EP1909106B1 (en) * 2001-09-14 2013-01-02 F. Hoffmann-La Roche AG Differential diagnosis of disorders of iron metabolism by means of four parameters and recommendations for the treatment of these disorders of iron metabolism
US6930086B2 (en) 2001-09-25 2005-08-16 Hoffmann-La Roche Inc. Diglycosylated erythropoietin
US7300915B2 (en) * 2002-06-05 2007-11-27 The Regents Of The University Of California Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
US7459435B2 (en) 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) * 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7964568B2 (en) * 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
US7772182B2 (en) * 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
US7586589B2 (en) * 2005-09-24 2009-09-08 Beckman Coulter, Inc. Methods of determination of responsiveness to erythropoietin treatment
WO2008019214A1 (en) 2006-08-04 2008-02-14 Prolong Pharmaceuticals, Inc. Modified erythropoietin
AR067536A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
AR067537A1 (es) * 2007-07-17 2009-10-14 Hoffmann La Roche Purificacion de polipeptidos pegilados
BR112015031027A2 (pt) * 2013-06-13 2017-08-29 Akebia Therapeutics Inc Uso de um composto, método in vitro, composição farmacêutica e forma de dosagem única
EP3789395A1 (en) 2015-11-23 2021-03-10 Bristol-Myers Squibb Company Pegylation of fgf21

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6039681B2 (ja) * 1976-01-01 1985-09-07 日本臓器製薬株式会社 デキストリン・クエン酸・第二鉄多核複合体及び該複合体を含有する非経口用鉄剤
IL77081A (en) 1984-12-04 1999-10-28 Genetics Inst AND sequence encoding human erythropoietin, a process for its preparation and a pharmacological preparation of human erythropoietin
JPS6231A (ja) * 1985-02-06 1987-01-06 Chugai Pharmaceut Co Ltd 腎性貧血治療剤
US4745099A (en) * 1985-02-06 1988-05-17 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of malignant tumors
KR880012235A (ko) * 1987-04-10 1988-11-26 벤자민 에프.람버트 정상 포유동물의 헤마토크릿을 증가시키는 방법

Also Published As

Publication number Publication date
EE03856B1 (et) 2002-10-15
HU225363B1 (en) 2006-10-28
SK285796B6 (sk) 2007-08-02
CZ291427B6 (cs) 2003-03-12
CN1202113A (zh) 1998-12-16
WO1997009996A1 (de) 1997-03-20
SK32798A3 (en) 1999-03-12
NO981136L (no) 1998-03-13
CZ72698A3 (cs) 1998-07-15
US6333306B1 (en) 2001-12-25
EP0851762B1 (de) 2002-04-17
AU724623B2 (en) 2000-09-28
KR19990044610A (ko) 1999-06-25
JPH11512414A (ja) 1999-10-26
UA57713C2 (uk) 2003-07-15
TR199800472T1 (xx) 1998-06-22
US20020049161A1 (en) 2002-04-25
HUP9900357A2 (hu) 1999-05-28
CN1133463C (zh) 2004-01-07
HUP9900357A3 (en) 2001-04-28
NO329908B1 (no) 2011-01-24
CA2231192C (en) 2003-02-25
PL325640A1 (en) 1998-08-03
KR100350761B1 (ko) 2003-03-03
JP4783482B2 (ja) 2011-09-28
ZA967732B (en) 1998-03-13
PT851762E (pt) 2002-08-30
IL123640A (en) 2006-06-11
ES2174107T3 (es) 2002-11-01
CA2231192A1 (en) 1997-03-20
BR9609971A (pt) 1999-09-14
DK0851762T3 (da) 2002-08-12
EE9800066A (et) 1998-08-17
MX9801922A (es) 1998-05-31
PL186776B1 (pl) 2004-02-27
ATE216256T1 (de) 2002-05-15
NZ319132A (en) 1999-09-29
DE19535571A1 (de) 1997-03-20
DE59609099D1 (de) 2002-05-23
DE19680768D2 (de) 1998-11-05
IL123640A0 (en) 1998-10-30
AU7128296A (en) 1997-04-01
EP0851762A1 (de) 1998-07-08

Similar Documents

Publication Publication Date Title
NO981136D0 (no) Farmasöytiske kombinasjonspreparater inneholdende erytropoietin og jernpreparater
IL112664A (en) 4-amino derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
IL112667A (en) 6-substituted derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
ATE263571T1 (de) Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen
DE69534676D1 (de) Orale Verabreichung von chemisch modifizierten Proteinen
HU911756D0 (en) Process for the production of medical preparations containing magnesium-pyridoxal-5'-phosphate-glutaminate, for the preventing of arterial diseases
ATE222118T1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate
DK0996462T3 (da) Farmaceutiske kombinationspræparater indeholdende erythropoietin og modificerede hæmoglobiner
CA2060560A1 (en) Method for insuring adequate intracellular glutathione in tissue
HU902004D0 (en) New trombolitic preparations
IL112668A (en) 4-Amino 6-substituted mycophenolic acid and derivatives thereof their preparation and pharmaceutical compositions containing them
IL112666A (en) 4-Amino derivatives of 5-substituted mycophenolic acid their preparation and pharmaceutical compositions containing them
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
TR199902305T2 (xx) Eritropoitein ve demir preperasyonları içeren farmasötik birleşimli preperasyonlar.
DE3771548D1 (de) Verwendung von carbonsaeure in fuer topische anwendung vorgesehenen pharmazeutischen zubereitungen.
UA19647A (uk) Спосіб лікуваhhя остеомієліту щелепи
GEU1999444Y (en) Medicinal Means “Barambo”
UA10219A (uk) Спосіб лікування туберкульозу легень

Legal Events

Date Code Title Description
MK1K Patent expired